Latest return on equity
Allogene Therapeutics Return on equity
Allogene Therapeutics (ALLO) return on equity with its verified observation dat…
Direct answer
Allogene Therapeutics's return on equity is -42.39%.
The verified market snapshot reports -42.39%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 28, 2026.
Get free Allogene Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -42.39%
Explore related company data
View Allogene Therapeutics's market capitalizationView Allogene Therapeutics's price-to-book ratioView Allogene Therapeutics's 52-week price rangeView Allogene Therapeutics's profit marginView Allogene Therapeutics's debt-to-equity ratioView all Allogene Therapeutics key metricsReturn to Allogene Therapeutics profile